CIK 0001348362 · Non-accelerated filer<br>Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 202000871
- Phone
- 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- S-1 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- D Other Notice of Sales of Unregistered Securities
- 424B5 Offering Prospectus
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Regulation FD disclosure
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
Page 7 of 55 · 1,098 filings